SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bacil Pharma - Quaterly Results

14 Aug 2023 Evaluate
A slight decline in the revenue of Rs. 0.00 millions was seen for the June 2023 quarter as against Rs. 0.00 millions during year-ago period.A slender decline of -19.05% was recorded to Rs. 0.17  millions from Rs. 0.21 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 0.18 millions from 0.22 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.48 0.65 -26.15 0.48 0.65 -26.15 1.15 0.58 98.28
PBIDT 0.18 0.22 -18.18 0.18 0.22 -18.18 -0.99 -38.56 -97.43
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.18 0.22 -18.18 0.18 0.22 -18.18 -0.99 -38.56 -97.43
Depreciation 0.01 0.01 0.00 0.01 0.01 0.00 0.03 0.04 -25.00
PBT 0.17 0.21 -19.05 0.17 0.21 -19.05 -1.02 -38.60 -97.36
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.17 0.21 -19.05 0.17 0.21 -19.05 -1.02 -38.60 -97.36
Equity 58.90 58.90 0.00 58.90 58.90 0.00 58.90 58.90 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bacil Pharma Share Price

54.01 -0.36 (-0.66%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×